{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "https://ymabs.com/#organization",
      "name": "Y-mAbs Therapeautics",
      "url": "https://ymabs.com/",
      "description": "About SERB Pharmaceuticals Bold Science, Innovative Medicines At Y-mAbs Therapeutics, we develop and commercialize novel radioimmunotherapy and antibody-based therapies to treat some of the most challenging diseases. Who we are Our science Our mission is to deliver innovative therapeutic solutions for life-threatening diseases to improve and extend people’s lives. Explore our science Our product Learn more about our first commercial product, DANYELZA®, (naxitamab-gqgk)."
    },
    {
      "@type": "WebPage",
      "@id": "https://directory.websdocs.com/business/y-mabs-therapeautics#asg",
      "name": "Y-mAbs Therapeautics ASG Directory Profile",
      "url": "https://directory.websdocs.com/business/y-mabs-therapeautics",
      "isPartOf": {
        "@id": "https://ymabs.com/#organization"
      },
      "description": "Public business information published by the WebsDocs ASG Directory."
    }
  ]
}